Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 724147, 7 pages
http://dx.doi.org/10.1155/2015/724147
Review Article

Intradialytic Hypotension and Cardiac Remodeling: A Vicious Cycle

1Renal Division, Department of Internal Medicine, National Taiwan University Hospital, Jin-Shan Branch, 51 Nan-Shih, Jin-Shan District, New Taipei City 208, Taiwan
2Graduate Institute of Toxicology, National Taiwan University Medical School, Section 1, 1 Jen-Ai Road, Zhong-Zheng District, Taipei 100, Taiwan
3Renal Division, Department of Internal Medicine, National Taiwan University Hospital, 7 Chung-Shan South Road, Zhong-Zheng District, Taipei 100, Taiwan
4Department of Geriatrics and Gerontology, National Taiwan University Hospital, 7 Chung-Shan South Road, Zhong-Zheng District, Taipei 100, Taiwan

Received 24 April 2014; Accepted 19 September 2014

Academic Editor: John J. Gildea

Copyright © 2015 Chia-Ter Chao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K/DOQI Workgroup, “K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients,” American Journal of Kidney Disease, vol. 45, no. 4, supplement 3, pp. S1–S153, 2005. View at Google Scholar
  2. F. M. Van Der Sande, J. P. Kooman, and K. M. L. Leunissen, “Intradialytic hypotension—new concepts on an old problem,” Nephrology Dialysis Transplantation, vol. 15, no. 11, pp. 1746–1748, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. J. T. Daugirdas, “Pathophysiology of dialysis hypotension: an update,” American Journal of Kidney Diseases, vol. 38, no. 4, pp. S11–S17, 2001. View at Google Scholar · View at Scopus
  4. T. Shoji, Y. Tsubakihara, M. Fujii, and E. Imai, “Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients,” Kidney International, vol. 66, no. 3, pp. 1212–1220, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. J. K. Inrig, E. Z. Oddone, V. Hasselblad et al., “Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients,” Kidney International, vol. 71, no. 5, pp. 454–461, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Calvo, S. Maule, F. Mecca, R. Quadri, G. Martina, and P. Cavallo Perin, “The influence of autonomic neuropathy on hypotension during hemodialysis,” Clinical Autonomic Research, vol. 12, no. 2, pp. 84–87, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Koremoto, N. Takahara, M. Takahashi et al., “Improvement of intradialytic hypotension in diabetic hemodialysis patients using vitamin E-bonded polysulfone membrane dialyzers,” Artificial Organs, vol. 36, no. 10, pp. 901–910, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. C.-T. Chao, Y.-F. Lin, H.-B. Tsai, V.-C. Wu, and W.-J. Ko, “Acute kidney injury network staging in geriatric postoperative acute kidney injury patients: shortcomings and improvements,” Journal of the American College of Surgeons, vol. 217, no. 2, pp. 240–250, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Lacquaniti, D. Bolignano, S. Campo et al., “Malnutrition in the elderly patient on dialysis,” Renal Failure, vol. 31, no. 3, pp. 239–245, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. J. T. Daugirdas, “Dialysis hypotension: a hemodynamic analysis,” Kidney International, vol. 39, no. 2, pp. 233–246, 1991. View at Publisher · View at Google Scholar · View at Scopus
  11. R. N. Foley, P. S. Parfrey, G. M. Kent, J. D. Harnett, D. C. Murray, and P. E. Barre, “Long-term evolution of cardiomyopathy in dialysis patients,” Kidney International, vol. 54, no. 5, pp. 1720–1725, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Paoletti, D. Bellino, P. Cassottana, D. Rolla, and G. Cannella, “Left ventricular hypertrophy in nondiabetic predialysis CKD,” American Journal of Kidney Diseases, vol. 46, no. 2, pp. 320–327, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. R. N. Foley, P. S. Parfrey, J. D. Harnett et al., “Clinical and echocardiographic disease in patients starting end-stage renal disease therapy,” Kidney International, vol. 47, no. 1, pp. 186–192, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. R. N. Foley, P. S. Parfrey, and M. J. Sarnak, “Clinical epidemiology of cardiovascular disease in chronic renal disease,” The American Journal of Kidney Diseases, vol. 32, pp. S112–S119, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Levy, K. M. Anderson, D. D. Savage, W. B. Kannel, J. C. Christiansen, and W. P. Castelli, “Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors: the Framingham heart study,” Annals of Internal Medicine, vol. 108, no. 1, pp. 7–13, 1988. View at Publisher · View at Google Scholar · View at Scopus
  16. R. J. Glassock, R. Pecoits-Filho, and S. H. Barberato, “Left ventricular mass in chronic kidney disease and ESRD,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 1, pp. S79–S91, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Brahimi, M. Dahan, H. Dabiré, and B. I. Levy, “Impact of pulse pressure on degree of cardiac hypertrophy in patients with chronic uraemia,” Journal of Hypertension, vol. 18, no. 11, pp. 1645–1650, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Zoccali, F. A. Benedetto, F. Mallamaci et al., “Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis,” Journal of the American Society of Nephrology, vol. 12, no. 12, pp. 2768–2774, 2001. View at Google Scholar · View at Scopus
  19. C. Zoccali, F. A. Benedetto, F. Mallamaci et al., “Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression,” Kidney International, vol. 65, no. 4, pp. 1492–1498, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. G. M. London, B. Pannier, A. P. Guerin et al., “Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study,” Journal of the American Society of Nephrology, vol. 12, no. 12, pp. 2759–2767, 2001. View at Google Scholar · View at Scopus
  21. F. O. B. Bonato, M. M. Lemos, J. L. Cassiolato, and M. E. F. Canziani, “Prevalence of ventricular arrhythmia and its associated factors in nondialyzed chronic kidney disease patients,” PLoS ONE, vol. 8, no. 6, Article ID e66036, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. P. M. Okin, C. N. Bang, K. Wachtell et al., “Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy,” Circulation: Arrhythmia and Electrophysiology, vol. 6, no. 2, pp. 243–251, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. J. O. Burton, S. Korsheed, B. J. Grundy, and C. W. McIntyre, “Hemodialysis-induced left ventricular dysfunction is associated with an increase in ventricular arrhythmias,” Renal Failure, vol. 30, no. 7, pp. 701–709, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. C.-T. Chao, C.-C. Hou, V.-C. Wu et al., “The impact of dialysis-requiring acute kidney injury on long-term prognosis of patients requiring prolonged mechanical ventilation: nationwide population-based study,” PLoS ONE, vol. 7, no. 12, Article ID e50675, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. J. J. Mourad, B. Pannier, J. Blacher et al., “Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension,” Kidney International, vol. 59, no. 5, pp. 1834–1841, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Miyoshi, Y. Oishi, Y. Mizuguchi et al., “Early predictors of alterations in left atrial structure and function related to left ventricular dysfunction in asymptomatic patients with hypertension,” Journal of the American Society of Hypertension, vol. 7, no. 3, pp. 206–215, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. T. S. M. Tsang, M. E. Barnes, B. J. Gersh, K. R. Bailey, and J. B. Seward, “Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden,” American Journal of Cardiology, vol. 90, no. 12, pp. 1284–1289, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. F. M. Fouad, J. M. Slominski, and R. C. Tarazi, “Left ventricular diastolic function in hypertension: relation to left ventricular mass and systolic function,” Journal of the American College of Cardiology, vol. 3, no. 6, pp. 1500–1506, 1984. View at Publisher · View at Google Scholar · View at Scopus
  29. S. H. Barberato and R. Pecoits Filho, “Valor prognóstico do índice do volume do átrio esquerdo em pacientes em hemodiálise,” Arquivos Brasileiros de Cardiologia, vol. 88, pp. 643–650, 2007. View at Google Scholar
  30. S. H. Barberato, M. Misocami, and R. Pecoits-Filho, “Association between left atrium enlargement and intradialytic hypotension: role of diastolic dysfunction in the hemodynamic complications during hemodialysis: CME,” Echocardiography, vol. 26, no. 7, pp. 767–771, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Tripepi, F. Mattace-Raso, F. Mallamaci et al., “Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease,” Hypertension, vol. 54, no. 4, pp. 818–824, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Tripepi, F. A. Benedetto, F. Mallamaci, R. Tripepi, L. Malatino, and C. Zoccali, “Left atrial volume in end-stage renal disease: a prospective cohort study,” Journal of Hypertension, vol. 24, no. 6, pp. 1173–1180, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Tripepi, F. A. Benedetto, F. Mallamaci, R. Tripepi, L. Malatino, and C. Zoccali, “Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study,” Journal of the American Society of Nephrology, vol. 18, no. 4, pp. 1316–1322, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Genovesi, A. Vincenti, E. Rossi et al., “Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients,” American Journal of Kidney Diseases, vol. 51, no. 2, pp. 255–262, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. W. C. Winkelmayer, A. R. Patrick, J. Liu, M. A. Brookhart, and S. Setoguchi, “The increasing prevalence of atrial fibrillation among hemodialysis patients,” Journal of the American Society of Nephrology, vol. 22, no. 2, pp. 349–357, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. C.-T. Chao, V.-C. Wu, C.-F. Lai et al., “Advanced age affects the outcome-predictive power of RIFLE classification in geriatric patients with acute kidney injury,” Kidney International, vol. 82, no. 8, pp. 920–927, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Bansal, D. Fan, C.-Y. Hsu, J. D. Ordonez, G. M. Marcus, and A. S. Go, “Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease,” Circulation, vol. 127, no. 5, pp. 569–574, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Zoccali, F. Mallamaci, R. Maas et al., “Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients,” Kidney International, vol. 62, no. 1, pp. 339–345, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. M. A. Alpert, “Cardiac performance and morphology in end-stage renal disease,” The American Journal of the Medical Sciences, vol. 325, no. 4, pp. 168–178, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. D. Levy, M. G. Larson, R. S. Vasan, W. B. Kannel, and K. K. L. Ho, “The progression from hypertension to congestive heart failure,” Journal of the American Medical Association, vol. 275, no. 20, pp. 1557–1562, 1996. View at Publisher · View at Google Scholar · View at Scopus
  41. G. M. London, A. P. Guerin, and S. J. Marchais, “Pathophysiology of left ventricular hypertrophy in dialysis patients,” Blood Purification, vol. 12, no. 4-5, pp. 277–283, 1994. View at Publisher · View at Google Scholar · View at Scopus
  42. C. W. Doering, J. E. Jalil, J. S. Janicki et al., “Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy,” Cardiovascular Research, vol. 22, no. 10, pp. 686–695, 1988. View at Publisher · View at Google Scholar · View at Scopus
  43. C. W. Chin, A. S. Shah, V. Vassiliou et al., “Left ventricular hypertrophy with strain and aortic stenosis,” Circulation, 2014. View at Publisher · View at Google Scholar
  44. D. Bernardi, L. Bernini, G. Cini, S. Ghione, and I. Bonechi, “Asymmetric septal hypertrophy and sympathetic overactivity in normotensive hemodialyzed patients,” American Heart Journal, vol. 109, no. 3, pp. 539–545, 1985. View at Publisher · View at Google Scholar · View at Scopus
  45. P. G. Camici, I. Olivotto, and O. E. Rimoldi, “The coronary circulation and blood flow in left ventricular hypertrophy,” Journal of Molecular and Cellular Cardiology, vol. 52, no. 4, pp. 857–864, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Kozhevnikov, E. B. Caref, and N. El-Sherif, “Mechanisms of enhanced arrhythmogenicity of regional ischemia in the hypertrophied heart,” Heart Rhythm, vol. 6, no. 4, pp. 522–527, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Wolk, “Arrhythmogenic mechanisms in left ventricular hypertrophy,” Europace, vol. 2, no. 3, pp. 216–223, 2000. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Kolb, T. M. Kitzler, T. Tauber, N. Morris, F. Skrabal, and P. Kotanko, “Proto-dialytic cardiac function relates to intra-dialytic morbid events,” Nephrology Dialysis Transplantation, vol. 26, no. 5, pp. 1645–1651, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. J. O. Burton, H. J. Jefferies, N. M. Selby, and C. W. McIntyre, “Hemodialysis-induced cardiac injury: determinants and associated outcomes,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 5, pp. 914–920, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Y. Zuidema and K. C. Dellsperger, “Myocardial stunning with hemodialysis: clinical challenges of the cardiorenal patient,” Cardiorenal Medicine, vol. 2, pp. 125–133, 2012. View at Google Scholar
  51. G. Graziani, S. Finazzi, R. Mangiarotti et al., “Different cardiovascular responses to hemodialysis-induced fluid depletion and blood pressure compliance,” Journal of Nephrology, vol. 23, no. 1, pp. 55–61, 2010. View at Google Scholar · View at Scopus
  52. E. Ritz, “Left ventricular hypertrophy in renal disease: Beyond preload and afterload,” Kidney International, vol. 75, no. 8, pp. 771–773, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. H. Schunkert, J.-I. Sadoshima, T. Cornelius et al., “Angiotensin II-induced growth responses in isolated adult rat hearts: evidence for load-independent induction of cardiac protein synthesis by angiotensin II,” Circulation Research, vol. 76, no. 3, pp. 489–497, 1995. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Tomita, D. Malhotra, S. Dheenan, J. I. Shapiro, W. L. Henrich, and T. J. Santoro, “A potential role for immune activation in hemodialysis hypotension,” Renal Failure, vol. 23, no. 5, pp. 637–649, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Sakurabayashi, S. Miyazaki, Y. Yuasa et al., “L-carnitine supplementation decreases the left ventricular mass in patients undergoing hemodialysis,” Circulation Journal, vol. 72, no. 6, pp. 926–931, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. P. Strózecki, A. Adamowicz, E. Nartowicz, G. Odrowa̧z-Sypniewska, Z. Włodarczyk, and J. Manitius, “Parathormon, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients,” Renal Failure, vol. 23, no. 1, pp. 115–126, 2001. View at Publisher · View at Google Scholar · View at Scopus
  57. C.-T. Chao, C.-F. Lai, and J.-W. Huang, “Risk factors for herpes zoster reactivation in maintenance hemodialysis patients,” European Journal of Internal Medicine, vol. 23, no. 8, pp. 711–715, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. S. van der Zee, A. Thompson, R. Zimmerman et al., “Vasopressin administration facilitates fluid removal during hemodialysis,” Kidney International, vol. 71, no. 4, pp. 318–324, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. K. E. Lynch, H. I. Feldman, J. A. Berlin, J. Flory, C. G. Rowan, and S. M. Brunelli, “Effects of L-carnitine on dialysis-related hypotension and muscle cramps: a meta-analysis,” American Journal of Kidney Diseases, vol. 52, no. 5, pp. 962–971, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. Y. L. Zhou, H. L. Liu, X. F. Duan, Y. Yao, Y. Sun, and Q. Liu, “Impact of sodium and ultrafiltration profiling on haemodialysis-related hypotension,” Nephrology Dialysis Transplantation, vol. 21, no. 11, pp. 3231–3237, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. F. Locatelli, P. Altieri, S. Andrulli et al., “Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD,” Journal of the American Society of Nephrology, vol. 21, no. 10, pp. 1798–1807, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. E. Mancini, E. Mambelli, M. Irpinia et al., “Prevention of dialysis hypotension episodes using fuzzy logic control system,” Nephrology, Dialysis, and Transplantation, vol. 22, pp. 1420–1427, 2007. View at Google Scholar
  63. C. Déziel, J. Bouchard, M. Zellweger, and F. Madore, “Impact of hemocontrol on hypertension, nursing interventions, and quality of life: a randomized, controlled trial,” Clinical Journal of the American Society of Nephrology, vol. 2, no. 4, pp. 661–668, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. N. M. Selby, S. H. Lambie, P. G. Camici, C. S. Baker, and C. W. McIntyre, “Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis,” American Journal of Kidney Diseases, vol. 47, no. 5, pp. 830–841, 2006. View at Publisher · View at Google Scholar · View at Scopus